Advancing Frontline Therapy in Metastatic NSCLC: Lessons From EVOKE-02 on Antibody–Drug Conjugates–Immunotherapy Combination

Journal of Thoracic Oncology 2026 Open access

Read full text

Authors: Ivy Riaño, Konstantin H. Dragnev

DOI: 10.1016/j.jtho.2025.12.003

Cited by: 0

References: 15

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers

References 15